BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19949928)

  • 1. Impact of breast cancer resistance protein on cancer treatment outcomes.
    Ross DD; Nakanishi T
    Methods Mol Biol; 2010; 596():251-90. PubMed ID: 19949928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABCG2: a perspective.
    Robey RW; To KK; Polgar O; Dohse M; Fetsch P; Dean M; Bates SE
    Adv Drug Deliv Rev; 2009 Jan; 61(1):3-13. PubMed ID: 19135109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood-brain barrier active efflux transporters: ATP-binding cassette gene family.
    Löscher W; Potschka H
    NeuroRx; 2005 Jan; 2(1):86-98. PubMed ID: 15717060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An emerging role of N-glycosylation in cancer chemoresistance.
    Sun Y; Wu T; Gu J
    Carbohydr Res; 2024 May; 539():109107. PubMed ID: 38613897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zinc Oxide Nanoparticles and Cancer Chemotherapy: Helpful Tools for Enhancing Chemo-sensitivity and Reducing Side Effects?
    Vaghari-Tabari M; Jafari-Gharabaghlou D; Mohammadi M; Hashemzadeh MS
    Biol Trace Elem Res; 2024 May; 202(5):1878-1900. PubMed ID: 37639166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-step synthesis of diaryloxadiazoles as potent inhibitors of BCRP.
    Yi W; Tran-Nguyen VK; Boumendjel A
    Future Med Chem; 2024 Apr; ():. PubMed ID: 38573062
    [No Abstract]   [Full Text] [Related]  

  • 7. Structure and function of the human breast cancer resistance protein (BCRP/ABCG2).
    Ni Z; Bikadi Z; Rosenberg MF; Mao Q
    Curr Drug Metab; 2010 Sep; 11(7):603-17. PubMed ID: 20812902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance.
    Natarajan K; Xie Y; Baer MR; Ross DD
    Biochem Pharmacol; 2012 Apr; 83(8):1084-103. PubMed ID: 22248732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression.
    Nakanishi T; Ross DD
    Chin J Cancer; 2012 Feb; 31(2):73-99. PubMed ID: 22098950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Research Progress of LncRNA SNHGs in Regulating the Biological Behavior 
of Non-small Cell Lung Cancer].
    Cao X; Chen L
    Zhongguo Fei Ai Za Zhi; 2023 Nov; 26(11):851-862. PubMed ID: 38061887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of ABCG2 Polymorphisms on Triple Negative Breast Cancer (TNBC) Susceptibility Risk.
    Hao Ing Y; Md Salleh MS; Yahya MM; Ankathil R; Abdul Aziz AA
    Asian Pac J Cancer Prev; 2023 Nov; 24(11):3891-3897. PubMed ID: 38019248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PI3K/AKT signaling pathway as a critical regulator of Cisplatin response in tumor cells.
    Navaei ZN; Khalili-Tanha G; Zangouei AS; Abbaszadegan MR; Moghbeli M
    Oncol Res; 2021; 29(4):235-250. PubMed ID: 37303943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ChemoSensitivity Assay Guided Metronomic Chemotherapy Is Safe and Effective for Treating Advanced Pancreatic Cancer.
    Isacoff WH; Cooper B; Bartlett A; McCarthy B; Yu KH
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating tumor and invasive cell expression profiling predicts effective therapy in pancreatic cancer.
    Yu KH; Park J; Mittal A; Abou-Alfa GK; El Dika I; Epstein AS; Ilson DH; Kelsen DP; Ku GY; Li J; Park W; Varghese AM; Chou JF; Capanu M; Cooper B; Bartlett A; McCarthy D; Sangar V; McCarthy B; O'Reilly EM
    Cancer; 2022 Aug; 128(15):2958-2966. PubMed ID: 35647938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABCG2 Protein Levels and Association to Response to First-Line Irinotecan-Based Therapy for Patients with Metastatic Colorectal Cancer.
    Palshof JA; Cederbye CN; Høgdall EVS; Poulsen TS; Linnemann D; Nygaard SB; Stenvang J; Christensen IJ; Jensen BV; Pfeiffer P; Brünner N; Yilmaz M; Viuff BM; Nielsen DL
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Side Population: Its Use in the Study of Cellular Heterogeneity and as a Potential Enrichment Tool for Rare Cell Populations.
    Wolmarans E; Nel S; Durandt C; Mellet J; Pepper MS
    Stem Cells Int; 2018; 2018():2472137. PubMed ID: 30627171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating Tumor and Invasive Cell Gene Expression Profile Predicts Treatment Response and Survival in Pancreatic Adenocarcinoma.
    Yu KH; Ricigliano M; McCarthy B; Chou JF; Capanu M; Cooper B; Bartlett A; Covington C; Lowery MA; O'Reilly EM
    Cancers (Basel); 2018 Nov; 10(12):. PubMed ID: 30477242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCRP expression in schwannoma, plexiform neurofibroma and MPNST.
    de Vries M; van Tellingen O; van der Mey AGL; Bunt AMG; Bruijn IB; Hogendoorn PCW
    Oncotarget; 2017 Oct; 8(51):88751-88759. PubMed ID: 29179472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody validation and scoring guidelines for ABCG2 immunohistochemical staining in formalin-fixed paraffin-embedded colon cancer tissue.
    Cederbye CN; Palshof JA; Hansen TP; Duun-Henriksen AK; Linnemann D; Stenvang J; Nielsen DL; Brünner N; Viuff BM
    Sci Rep; 2016 Jun; 6():26997. PubMed ID: 27257141
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.